Fig. 3.
Fig. 3. Presence of p210BCR/ABL in normal CD34+ cells inhibits adhesion of CFCs to fibronectin. / p210-eGFP– (▪) or eGFP-transduced (■) GFP+CD34+ cells (104) from 4 umbilical cord blood samples were plated in 24-well plates coated with 100 μg/mL fibronectin (FN, left) or 5% BSA (right) for 2 hours. Nonadherent cells and adherent cells were collected separately and plated in methylcellulose progenitor assay. The percentage of adherent CFCs was calculated as [no. adherent CFCs/(no. adherent CFCs + no. nonadherent CFCs)] × 100. The number of CFCs in the nonadherent + adherent population was 66 ± 6/1000 cells for eGFP-transduced GFP+ CD34+ cells and 268 ± 25/1000 cells for p210-eGFP–transduced GFP+CD34+ cells. Comparison between p210-eGFP– and eGFP-transduced GFP+ CD34+ cells (P = .001).

Presence of p210BCR/ABL in normal CD34+ cells inhibits adhesion of CFCs to fibronectin.

p210-eGFP– (▪) or eGFP-transduced (■) GFP+CD34+ cells (104) from 4 umbilical cord blood samples were plated in 24-well plates coated with 100 μg/mL fibronectin (FN, left) or 5% BSA (right) for 2 hours. Nonadherent cells and adherent cells were collected separately and plated in methylcellulose progenitor assay. The percentage of adherent CFCs was calculated as [no. adherent CFCs/(no. adherent CFCs + no. nonadherent CFCs)] × 100. The number of CFCs in the nonadherent + adherent population was 66 ± 6/1000 cells for eGFP-transduced GFP+ CD34+ cells and 268 ± 25/1000 cells for p210-eGFP–transduced GFP+CD34+ cells. Comparison between p210-eGFP– and eGFP-transduced GFP+ CD34+ cells (P = .001).

Close Modal

or Create an Account

Close Modal
Close Modal